Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

not_yet_recruiting125%
recruiting375%

Recent Activity

3 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

NCT06438055
recruitingnot_applicable

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

NCT06246630
recruitingnot_applicable

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

NCT06406608
recruitingnot_applicable

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

NCT06406660

Clinical Trials (4)

Showing 4 of 4 trials
NCT06438055Not Applicable

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

Not Yet Recruiting
NCT06246630Not Applicable

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Recruiting
NCT06406608Not Applicable

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

Recruiting
NCT06406660Not Applicable

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4